Home » Topics » Regulatory » Patents

Patents
RSS

Novel vitronectin receptor antagonists in early development at SB

May 19, 1999

Merck's new carbapenems useful against methicillin-resistant staphylococci

May 18, 1999

Lilly synthesizes potent and selective 5-HT4 receptor antagonists or partial agonists

May 18, 1999

Pharmacologically useful PTPase inhibitors developed by Ontogen and Novo Nordisk

May 18, 1999

Sanofi reports preparation and use of new cholecystokinin agonists

May 18, 1999

Phospholamban inhibitors described by Orion for use in heart failure

May 18, 1999

New vitronectin receptor ligands for osteoporosis, etc., synthesized by HMR and Genentech

May 18, 1999

Cytokine-suppressive antiinflammatory agents in development at SmithKline Beecham

May 18, 1999

SmithKline Beecham describes new series of CCR5 receptor modulators

May 17, 1999

Abbott prepares semisynthetic rapamycin analogues with reduced half-lives

May 17, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...